Status:

COMPLETED

TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin

Lead Sponsor:

University Hospital, Angers

Conditions:

Peripheral Arterial Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Prospective interventional study. The aim is to analyze the effect of usual ongoing treatments over microvascular cutaneous response to galvanic current applications (CIV: current induced vasodilatati...

Detailed Description

At admission eligible patients are proposed to participate. Written consent is signed after complete oral and written explanation of the protocol is signed. No register of non-included patients will ...

Eligibility Criteria

Inclusion

  • subjects referred for investigation of peripheral arterial disease.
  • Affiliation to the French National healthcare system
  • French speaking patients
  • Ability to stand still for half a minute.

Exclusion

  • pregnancy
  • inability to understand the study goal
  • Patients protected by decision of law

Key Trial Info

Start Date :

February 8 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 26 2021

Estimated Enrollment :

830 Patients enrolled

Trial Details

Trial ID

NCT03357367

Start Date

February 8 2018

End Date

September 26 2021

Last Update

June 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UH Angers

Angers, France, 49100

TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin | DecenTrialz